EVER Pharma
Michael Smrcka has a diverse range of work experience, with their most recent role as the CFO at EVER Neuro Pharma since 2019. Prior to that, they worked as the Finance Director at Patheon Austria Gmbh & Co KG from 2017 to 2019. Michael also served as the Managing Director at Robol Smrcka Robol from 2013 to 2016. In addition, they held various positions at Kapsch CarrierCom AG, including Head of Finance CEE & Asia from 2010 to 2012, Head of Controlling from 2010 to 2012, and Teamleader Subsidiary Controlling from 2008 to 2010. Before that, they were the Managing Director at AN-COR-TEK C.E GmbH from 2006 to 2008 and worked as a Consultant & Project Manager at Ecos Management GmbH from 2003 to 2006.
Michael Smrcka attended WU (Vienna University of Economics and Business) from 1998 to 2002, where they earned a Magister degree in Business Administration. In 2001, they also briefly attended the University of Nebraska at Omaha, although no specific degree or field of study is mentioned.
This person is not in the org chart
This person is not in any offices
EVER Pharma
EVER Pharma is a fully integrated specialty pharmaceuticals company focused on the research, development, production, and commercialization of products in the areas of neurology and specialty injectables, covering oncology, intensive care and hormone therapeutics. From our headquarters in Austria, we run a dynamic operation providing innovative products and value-added formulations aimed at enhancing the lives of patients and supporting the work of healthcare professionals through improved convenience and safety. Our products are developed and manufactured at our EU GMP certified facilities in Austria and Germany. These are highly specialized in the production of complex injectables including high potency and controlled substances, crystal suspensions, as well as oily solutions in vials, pre-filled syringes, cartridges, implants, and ampoules. We market our products in more than 70 countries around the world through our own international affiliates and strategic partners.